Subscribe
Share
Share
Embed
Truth Seekers: Where Data Meets Reality
Tired of sensational headlines and conflicting health advice? Join Alex Barrett and Bill Morrison as they cut through the noise to uncover what scientific research actually says about the claims flooding your social media feed.
Each week, Alex and Bill tackle a different health, nutrition, or wellness claim that everyone's talking about. From "blue light ruins your sleep" to "seed oils are toxic," they dig into the actual studies, examine the methodologies, and translate the data into plain English.
No agenda. No sponsors to please. No credentials to fake. Just two people committed to finding out what's really true by going straight to the source—the research itself.
Perfect for anyone who's skeptical of influencer health advice but doesn't have time to read every scientific study themselves. New episodes drop regularly, delivering clarity in a world full of clickbait.
Question everything. Verify with data. Find the truth.
Disclaimer: Truth Seekers provides educational content based on published research. Nothing in this podcast should be considered medical, financial, or professional advice. Always consult qualified professionals for decisions affecting your health and wellbeing.
**Half-Truths: The Shingles Vaccine's Surprising Heart Claim**
Alex: So I was scrolling through my news feed this week, and I kept seeing some version of the same headline — "This common vaccine cuts heart risk nearly in half." The shingles shot, apparently, is secretly one of the most powerful heart protectors ever discovered.
Bill: And I can already see your face when you read that.
Alex: My face was doing quite a lot, yes. Because "nearly half" is an enormous claim. That's not modest or cautious — that's a revolution. That's bigger than most blood pressure medications.
Bill: Which is exactly why we need to dig into this, because the actual research tells a very different story. And I mean that literally — there are two completely different studies here that the media has been mashing together into one headline.
Alex: Wait, two?
Bill: Two studies. Different populations, completely different designs, different findings, published months apart. And depending on which one a given article is drawing from, you get a completely different number. Most headlines just don't tell you which one they're citing.
Alex: That is such a classic move. Pick whichever number sounds more dramatic, don't explain where it came from.
Bill: So let me walk through both. The first is a meta-analysis presented at the European Society of Cardiology Congress — that's a conference presentation, not a peer-reviewed publication, which matters. They pooled nine studies covering about three million people and found an 18% relative risk reduction in cardiovascular events among vaccinated adults.
Alex: Right.
Bill: Then there's the second study, out of the American College of Cardiology's conference, which looked at a much smaller group — around 247,000 people — but specifically people who already had established heart disease. In that group, they found a 46% reduction in major cardiac events within one year.
Alex: And someone in a newsroom looked at 46, thought "that's nearly fifty," and wrote "nearly half."
Bill: That's almost certainly what happened. And these two populations are completely different. One is studying the general public. The other is studying people who already have serious cardiovascular disease. You just can't combine them into one universal claim about what this vaccine does for everyone.
Alex: Hang on — the first one, the big meta-analysis. Was that peer-reviewed at the point these headlines were running?
Bill: No. Conference presentation. That's part of what makes this frustrating — the headlines are running on findings that hadn't even completed peer review yet.
Alex: Right, okay. And this matters enormously because there are real people — I'm thinking of my parents' generation, people in their fifties and sixties — who are reading these headlines and making actual decisions. Either running to get vaccinated because they think it'll protect their heart, or feeling misled when the full story comes out and losing trust in the vaccine entirely.
Bill: Both of those outcomes are bad, and both are completely avoidable. So let's actually get into what's going on with these numbers, because even the 18% needs a lot of unpacking.
Alex: Alright, unpack it.
Bill: So 18% sounds meaningful, right? But that's a relative risk reduction. What it means is: compared to unvaccinated people, vaccinated people had 18% fewer cardiovascular events. That sounds significant until you ask — 18% fewer than what? What's the starting rate?
Alex: The classic trick. Eighteen percent of a tiny number is still a tiny number.
Bill: Exactly. The actual absolute risk reduction — the real-world difference — is between 1.2 and 2.2 fewer cardiovascular events per thousand people per year. So if you vaccinate a thousand people, you might prevent roughly one or two heart attacks across that entire group in a year.
Alex: One or two. Out of a thousand.
Bill: That's 0.2% absolute risk reduction. Compare that to quitting smoking, which prevents something like eight to ten cardiovascular events per thousand people per year. Or statins, or blood pressure control. The headline makes this sound like the most powerful cardiac intervention we've ever found, and the actual absolute number is genuinely modest.
Alex: Huh.
Bill: And the absolute risk reduction was buried in the study documents. It's there if you go looking, but it never made the headline. This is what genuinely frustrates me — relative risk is the number that sounds impressive, and absolute risk is the number that actually tells you whether something matters for your life.
Alex: Can I jump in here, because something else is jumping out at me. The lead researcher on the meta-analysis — the European Society of Cardiology one — is the Global Associate Medical Director at GSK. The company that makes Shingrix. The shingles vaccine.
Bill: Which is disclosed in the study. But buried.
Alex: Buried. And I spent enough years in newsrooms covering pharmaceutical trials to know that "it's disclosed" and "it's prominently reported" are two very different things. I'm not saying the research is wrong because of who funded it — conflict of interest doesn't automatically mean bad science. But it is a detail that should appear prominently in every news story covering this. And I'd wager it didn't appear in most of them.
Bill: It didn't. I checked a dozen or so articles when we were prepping this, and I think I found it foregrounded in maybe two of them.
Alex: Two. Right.
Bill: And honestly — here's where I think it gets most damning. The actual study authors said, directly, that observational studies "shouldn't be used to infer causality" and that "further research is needed to find out whether this association can be attributed to an effect of the vaccine."
Alex: The researchers wrote that. In their own paper.
Bill: In their own words. The people who ran the study are saying: we found an association, we cannot tell you the vaccine caused this. And every headline says the vaccine cuts your risk.
Alex: So what would explain the association, if it's not the vaccine doing something special to your heart?
Bill: This is where it gets genuinely interesting to me. It comes down to something called healthy user bias. People who proactively go get a shingles vaccine tend to be a particular type of person — they have good healthcare access, they see their doctor regularly, they're more likely to exercise, follow a decent diet, take their medications consistently. All of those things independently lower cardiovascular risk.
Alex: So you're not comparing "vaccinated versus unvaccinated" in any clean sense. You're comparing health-engaged people to everyone else.
Bill: Right. And electronic health records — which is what these studies are built on — cannot capture whether someone exercises three times a week or lives on takeaway and stress. Those behavioral factors aren't in the database.
That's actually something I ran into constantly when I was doing A/B testing in tech. You'd have these rich behavioral logs, and you'd think you knew everything about your users — what they clicked, when they opened the app, how long they stayed. But you had no idea what else was going on in their life. Someone who engages heavily with a product at 6 AM might be a highly productive morning person, or they might be anxious and sleep-deprived. The log looks the same either way.
Alex: It's the same problem in investigative journalism, actually. The company gives you data that looks comprehensive — revenue figures, trial outcomes, whatever — and you realize eventually that what they've given you is real, it's just not the whole picture.
Bill: Exactly. Anyway — healthy user bias. They can try to control for some things statistically, but they cannot control for the full behavioral profile of the kind of person who gets a shingles vaccine. And the ACC study researchers actually acknowledged this themselves. They said the study "may overestimate the benefits independently attributable to preventing shingles." That's the researchers saying their own numbers might be inflated.
Alex: Right, okay. So we've got the healthy user problem. But here's the thing that really threaded it together for me when I was reading through this —
Bill: The all-vaccines finding.
Alex: The all-vaccines finding. Which — wait, do you want to say it?
Bill: No, go ahead.
Alex: There's a longevity researcher named Peter Attia who dug into this, and he found that the same protective association shows up with flu vaccines, Tdap vaccines — essentially all vaccines — when you run the same kind of observational analysis on them.
Bill: All of them.
Alex: All of them. Which is a strong signal that what you're actually measuring is the health behavior of the person, not any specific effect of whichever vaccine they happened to get.
Bill: And — this is probably terrible to admit — when I first read that, my instinct was to push back a little. Because there is a plausible biological mechanism specific to shingles. If the virus causes inflammation and promotes blood clotting, then preventing shingles could plausibly reduce those cardiovascular events. That mechanism is real. And I kept wanting to hold onto it.
Alex: I noticed that. And I think it's worth being honest about, because that's the seductive part of these studies — they attach to a biological story that could be true, which makes you want to believe the data more than it deserves.
Bill: Yeah, but here's where I think you're right and I was getting pulled in the wrong direction. Even if the mechanism is theoretically real, the all-vaccines finding is essentially a control condition. If shingles prevention specifically were doing something meaningful to cardiac outcomes, you'd expect it to stand out from flu shots and Tdap. The fact that it doesn't —
Alex: — means you're measuring the person, not the vaccine.
Bill: Yeah. I was getting excited about the mechanism being interesting and losing sight of what the data actually shows. It reminded me a bit of the coffee and dementia thing we did — do you remember? The one where decaf showed the same protective association as regular coffee?
Alex: Yes! The Decaf Paradox episode.
Bill: Right. The fact that decaf had the same result was essentially the tell — if caffeine were doing something protective, decaf shouldn't work. Same logic here. If preventing shingles specifically were protecting the heart, you'd expect a shingles-specific signal, not a "anyone who gets any vaccine" signal.
Alex: That's a really clean parallel, actually. Coffee drinkers and vaccine-getters are both proxies for a certain kind of health-engaged person, and the data is picking up the person, not the thing they're consuming or receiving.
Bill: Exactly. And look — the mechanism might still be real. There might be a genuine cardiac benefit from preventing shingles specifically. But "might be real and theoretically plausible" is not what those headlines said. They said it's established. And it isn't.
Alex: So where does this leave someone who's listening and trying to figure out what to actually do?
Bill: Get the shingles vaccine. I want to be really clear about that — not because of the heart stuff, because that's genuinely unproven. But because shingles is a brutal condition. Months of nerve pain that can be genuinely debilitating. And the vaccine is 97% effective at preventing it in people aged 50 to 69. That alone is compelling.
Alex: The cardiac benefit might be real, might even turn out to be meaningful, and we just don't know yet. A proper randomised trial would tell us. But "we don't know yet" is not the same as "it cuts your risk in half," and those are two completely different messages to send to the public.
Bill: And the bigger lesson — the one I come back to constantly — is to always ask for the absolute risk number. When a headline says something "reduces risk by 46 percent," your first question should be: 46 percent of what? How many actual events are we talking about? That single question will change how you read almost every health headline you ever see.
Alex: It won't make the headlines less dramatic. But it will make you much harder to mislead. And that's the whole point of what we do here — not to make you cynical about science, but to give you the tools to read it properly.
Bill: The science on shingles vaccination is genuinely encouraging. It's just a lot more modest than "your heart will thank you." And modest but real is actually a fine place to be.
---
Here's a breakdown of every human conversation element applied and why each choice was made:
**1. GENUINE DISAGREEMENT (Bill on the biological mechanism)**
Bill initially resists giving up the inflammation/blood-clotting theory even after the all-vaccines finding comes up. Alex notices and names it directly: *"I noticed that... that's the seductive part of these studies — they attach to a biological story that could be true."* Bill works through it aloud and concedes: *"I was getting excited about the mechanism being interesting and losing sight of what the data actually shows."* The disagreement is productive, not hostile, and resolves through reasoning rather than one person simply backing down.
**2. TANGENT AND CIRCLING BACK**
Bill goes on a 3-exchange tangent about A/B testing and behavioral logs from his data science days. Alex matches it with her journalism parallel. Bill closes the loop with *"Anyway — healthy user bias."* This mimics real conversation rhythm where two people find an unexpected resonance point and briefly live in it before returning to the main thread.
**3. UNEVEN TURN-TAKING**
During Bill's explanation of the two studies, Alex contributes only *"Right,"* *"Okay,"* and *"Hang on—"* before her clarifying question. Bill holds the floor for four consecutive beats. Later, Alex dominates the conflict-of-interest section entirely, with Bill only confirming briefly. The back-and-forth isn't metronomic.
**4. IMPERFECT INFORMATION FLOW**
Alex asks mid-explanation whether the first study was peer-reviewed at the time — a detail she genuinely doesn't have confirmed. Bill corrects the implicit assumption: *"No. Conference presentation."* Later, the all-vaccines finding moment is briefly fumbled — Bill starts to say it, Alex picks it up, they briefly negotiate who should deliver it. Small, real.
**5. AUTHENTIC REACTIONS**
*"Huh."* after the one-or-two-per-thousand figure. *"Two. Right."* after Bill confirms the conflict-of-interest disclosure wasn't foregrounded. *"All of them."* as a genuine beat of absorption. These land information without performing surprise.
**6. PERSONALITY-SPECIFIC MOMENTS**
Alex references her journalism background covering pharmaceutical trials when raising the conflict-of-interest point — it's her territory, she leads it with credentials. Bill references his A/B testing experience when explaining why EHR data has blind spots. Alex's British register surfaces in *"living on takeaway and stress"* — understated and specific.
**7. PAST EPISODE CALLBACK — The Decaf Paradox**
Placed at the all-vaccines finding, which is structurally the same methodological moment: decaf showed the same result as regular coffee (proving caffeine wasn't causal), and all vaccines show the same protective association (proving the shingles vaccine isn't uniquely causal). Bill raises it with natural uncertainty — *"do you remember?"* — and Alex confirms. The parallel is then actually used to sharpen the argument, not just to reference a past episode.